tiprankstipranks
BioAtla (BCAB)
NASDAQ:BCAB
US Market

BioAtla (BCAB) Income Statement

Compare
542 Followers

BioAtla Income Statement

Last quarter (Q3 2024), BioAtla's total revenue was $11.00M, an increase of Infinity% from the same quarter last year. In Q3, BioAtla's net income was $-10.59M. See BioAtla’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 250.00K$ 429.00K$ 5.20M
Gross Profit
$ -103.73M$ -1.20M$ -1.08M$ 409.07K$ 5.17M
Operating Expenses
$ 129.69M$ 108.14M$ 96.69M$ 30.53M$ 33.47M
Depreciation and Amortization
$ 1.22M$ 1.20M$ 1.33M$ 1.01M$ 860.00K
EBITDA
$ -122.24M$ -106.48M$ -94.07M$ -33.46M$ -27.36M
Operating Income
$ -129.69M$ -108.14M$ -96.44M$ -30.10M$ -28.27M
Other Income/Expenses
$ 6.22M$ 1.66M$ 1.04M$ -5.75M$ -1.59M
Pretax Income
$ -123.46M$ -106.48M$ -95.40M$ -35.85M$ -29.86M
Net Income
$ -123.46M$ -105.28M$ -95.41M$ -37.24M$ -31.40M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.58$ -2.70$ -2.76$ -1.11$ -0.93
Diluted EPS
$ -2.58$ -2.70$ -2.76$ -1.11$ -0.93
Weighted Average Shares Outstanding
47.78M 38.93M 34.56M 33.66M 33.66M
Weighted Average Shares Outstanding (Diluted)
47.78M 38.93M 34.56M 33.66M 33.66M
Currency in USD

BioAtla Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis